PACB · Pacific Biosciences Of California, Inc. · Share Buybacks
$1.86
-0.10 (-5.09%)
At close · Nov 16
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$613.34M
Shares
312.93M
Volume · Nov 16
4.92M
Avg daily vol (3M)
12.42M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-11-10 | — | $100,000,000 | — | — | 8-K , filed 2026-11-10 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2009-12-31 | $8,000 | 10-K, filed 2012-03-01 |
Key facts
CIK
1299130
CUSIP
69404D108
13F (30d)
158 filings
139 filers
Visit website
Investor relations